Current readmission risk prediction models perform poorly and require improvement before widespread clinical or comparative use.
Answers are grounded in this paper and cite their sources.
Current readmission models warrant caution for clinical or comparative use; leaves open need for improved tools.
Most current readmission risk prediction models that were designed for either comparative or clinical purposes perform poorly. Although in certain settings such models may prove useful, efforts to improve their performance are needed as use becomes more widespread.
No takes yet. Share an insight, caveat, or question.
Kansagara et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: